Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Three key studies were carried out on Magnesium hydroxide and Magnesium Carbonate and Magnesium oxide, gene mutation in bacteria. These results of all studies were negative. Therefore upsalite is not classified as mutagenic.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25.2.2010-11.3.2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Certified
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- in vitro gene mutation study in bacteria
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- in vitro gene mutation study in bacteria
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- Identification: Magnesium hydroxide
Molecular Formula: Mg(OH)2
Molecular weight: 58.32 - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver microsomal enzymes were routinely prepared from adult male Wistar rats
- Test concentrations with justification for top dose:
- In the dose range finding test, Magnesium hydroxide was tested up to concentrations of 5000 µg/plate. Based on these results Magnesium hydroxide was tested in the first mutation assay at a concentration range of 100 to 5000 µg/plate. In an independent repeat of the assay, Magnesium hydroxide was tested at the same concentration range as the first assay.
- Vehicle / solvent:
- DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Dimethyl sulfoxide
- Positive controls:
- yes
- Positive control substance:
- other:
- Details on test system and experimental conditions:
- Test system: Salmonella typhimurium bacteria and Escherichia coli bacteria.
The Salmonella typhimurium strains were regularly checked to confirm their histidine-requirement, crystal violet senesitivity, ampicillin resistance (TA98 and TA100), UV-sensitivity and the number of spontaneous revertants.
The Escherichia coli WP2uvrA strain was regularly checked to confirm the tryptophan-requirement, UV-sensitivity and the number of spontaneous revertants.
Stock cultures of the five strains were stored in liquid nitrogen (-196°C). - Evaluation criteria:
- No formal hypothesis testing was done.
A test substance is considered negative (not mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 is not greater than two (2) times the concurrent control, and the total number of revertants in tester strains TA1535, TA1537, TA98 or WP2uvrA is not greater than three (3) times the concurrent control.
b) The negative response should be reproducible in at least one independently repeated experiment.
A test substance is considered positive (mutagenic) in the test if:
a) The total number of revertants in tester strain TA100 is greater than two (2) time the concurrent control, or the total number of revertants in tester strains TA1535, TA1537, TA98 or WP2uvrA is greater than three (3) time the concurrent control.
b) In case a repeat experiment is performed when a positive response is observed in one of the tester strains, the positive response should be reproducible in at least one independently repeated experiment.
The preceding criteria were not absolute and other modifying factors might enter into the final evaluation decision. - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- All bacteria strains showed negative responses over the entire dose range, i.e. no significant dose-related increase in the number of revertants in two repeated experiments.
The negative strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that Magnesium hydroxide is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay. - Executive summary:
Evaluation of the mutagenic activity of Magnesium hydroxide in theSalmonella typhimuriumreverse mutation assay and theEscherichia colireverse mutation assay (with independent repeat).
Magnesium hydroxide was tested in theSalmonella typhimuriumreverse mutation assay with four histidine-requiring strains ofSalmonella typhimurium(TA1535, TA1537, TA98 and TA100) and in theEscherichia colireverse mutation assay with a tryptophan-requiring strain ofEscherichia coli(WP2uvrA). The test was performed in two independent experiments in the presence and absence of S9-mix (rat liver S9-mix induced by a combination of Phenobarbital and β-naphthoflavone).
The study procedures described in the report were based on the most recent OECD and EC guidelines.
In the dose range finding test, Magnesium hydroxide was tested up to concentrations of 5000 µg/plate in the absence and presence of S9-mix in the strains TA100 and WP2uvrA. Magnesium hydroxide did not precipitate on the plates at this dose level. The bacterial background lawn was not reduced at any of the concentrations tested and no biologically relevant decrease in the number of revertants was observed. Results of this dose range finding test were reported as part of the first experiment of the mutation assay.
Based on the results of the dose range finding test, Magnesium hydroxide was tested in the first mutation assay at a concentration range of 100 to 5000 µg/plate in the absence and presence of 5% (v/v) S9-mix in tester strains TA1535, TA1537 and TA98. In an independent repeat of the assay with additional parameters, Magnesium hydroxide was tested at the same concentration range as the first assay in the absence and presence of 10% (v/v) S9-mix in tester strains TA1535, TA1537, TA98, TA100 and WP2uvrA. The bacterial background lawn was not reduced at any of the concentrations tested and no biologically relevant decrease in the number of revertants was observed.
Magnesium hydroxide did not induce a significant dose-related increase in the number of relevant (His+) colonies in tester strain WP2uvrA both in the absence and presence of S9-metabolic activation. The results were confirmed in an independently repeated experiment.
In this study, the negative and strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that Magnesium hydroxide is not mutagenic inSalmonella typhimuriumreverse mutation assay and in theEscherichia colireverse mutation assay.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- n/a
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- Yahagi's method
- Deviations:
- yes
- Remarks:
- SA98 and SA100
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- MgO powder slurry, Magnesium oxide powder (Kishida Chemical, Osaka, Japan) with a mean particle size of 3.6 um was used as the test material. The powder was heated at 180 °C for 20 min and suspended with sterile saline to yield the
specified concentrations. - Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- The S9 fraction is the supernatant obtained from centrifuging mammalian rat liver homogenates at 9,000 x g, and contains metabolic activating enzymes.
The components of the standard S9 mix are 8mM magnesium chloride, 33mM KCl, 5 mM glucose-6-phosphate, 4mM NAPD, 100mM sodium phosphate, pH7,4 and S9 in concentration of 0,04 ml per ml of mix. - Test concentrations with justification for top dose:
- During preincubation for 20 min the number of viable cells of the tester strains decreased at concentrations of the magnesium oxide powder over 5 g/l. The mutagenicity of the test material, has to be tested below the concentration where there is no decrease in the number of viable cells of the tester strains. So both the mutagenicity and antimutagenicity tests were carried out at lower than those powder concentrations.
- Details on test system and experimental conditions:
- Salmonella typhimurium TA98 and TA100 were used as the tester strains. The tester strains were incubated in nutrien broth No2 at 310 K for 10h. The broth contains 10 g of "lab-Lemco" powder, 5g of peptone and 5g of NaCl per liter. The mutagenicity of the test materials was examined according to the Ames test. A mixture of the ceramic powder slurry, the tester strain culture and 0,1M phosphate buffer (pH7,0) or S9 mix was preincubated in a water bath shaker at 310K for 20 min. The top agar was added to the mixture. This compund was poured onto a minimal essential glucose plate containing 1,5% agar and 2% glucose in Vogel-Bonner medium. The plates were incubated at 310K. The number of revertant colonies was counted after 48 h.
- Evaluation criteria:
- N (c)/N (s) shows the ratio of hte number of revertant colonies induced byt the ceramics powder tho that of spontaneous revertant colonies. When the value of N(c)/N(s) was greater than 2.0, the materials were considered to be mutagenic.
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Conclusions:
- The MgO powder was not mutagenic in both the presence and the absence of metabolic activation by addition of S9 mix.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- The bacterial strains are slightly different to those recommended in the guideline. Some details regarding the method and results are not described in the report.
- Deviations:
- yes
- Remarks:
- The bacterial strains tested are slightly different to those recommended in the guideline. Some details regarding the method and results are not described in the report.
- Principles of method if other than guideline:
- Salmonella/microsome test (Ames test) were carried out on 190 synthetic food additives and 52 food additives derived from natural sources, all of which area currently used in JApan. One of the test materials used in the study was Magnesium Chloride.
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- other: TA92
- Species / strain / cell type:
- other: TA94
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver microsome fraction (S-9)- prepared from the liver of Fischer rats.
- Test concentrations with justification for top dose:
- Maximum dose 100mg/plate, represent the highest non-cytotoxic dose used in the experiment.
- Vehicle / solvent:
- Solvent; distilled water
- Negative solvent / vehicle controls:
- yes
- Details on test system and experimental conditions:
- Cell cultured overnight were pre-incubated with both the test sample and the S9 mix for 20 min at 37 C before plating. Duplicate plates were used for each of six different concentrations of the sample. the number of revertant (his +) colonies was scored after incubation at 37C for 2 days.
- Evaluation criteria:
- The result was considered positive if the number of colonies found was twice the number in the control.
- Species / strain:
- S. typhimurium, other: TA92, TA 94, TA98, TA100, TA1535, TA1537TA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not specified
- Additional information on results:
- No significant increases in the number of revertant colonies were detected in any S typhimurium strains at the maximum dose.
- Remarks on result:
- other: all strains / cell type tested
- Conclusions:
- Magnesium chloride was considered to be non-mutagenic under the conditions of this test.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity:Chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- na
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- No metabolic activation systems were applied. Some details regarding the method and results are not described in the report.
- Principles of method if other than guideline:
- Chromosomal aberration tests in vitro were carried out using a Chinese hamster fibroblast cell line on 190 synthetic food additives and 52 food additives derived from natural sources, all of which are currently used in Japan. One of the test materials used in the study was magnesium chloride.
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian chromosome aberration test
- Specific details on test material used for the study:
- Purity 96,3%
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- Maximum dose: 2.0 mg/mL (represents the highest non-cytotoxic dose used in the experiment)
- Vehicle / solvent:
- physiol. saline
- Negative solvent / vehicle controls:
- yes
- Details on test system and experimental conditions:
- The cells were exposed to the test sample at 3 different doses for 24 and 48 hours. No metabolic activation systems were applied. The maximum dose was selected by a preliminary test in which the dose needed for 50% cell growth inhibition was estimated using a cell densitometer.
The incidence of polyploid cells as well as of cells with structural chromosomal aberrations such as chromatid or chromosome gaps, breaks, exchanges, ring formations, fragmentations and others were recorded on each culture plate.
Untreated cells and solvent treated cells served as negative controls in which the incidence of aberrations was usually less than 3.0%. - Evaluation criteria:
- The results were considered to be negative if the incidence was less than 4.9%, equivocal if it was between 5.0 and 9.9% and positive if it was more than 10.0%.
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Additional information on results:
- The incidence of polyploid cells at 48 h after treatment: 1.0%. The incidence of cells with structural chromosomal aberrations at 24 h after treatment: 2.0%
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- Magnesium chloride was considered to be non-mutagenic under the conditions of this test.
Referenceopen allclose all
Dose range finding test
Magnesium hydroxide was tested in the tester strains TA100 and WP2uvrA with concentrations of 3,10, 33, 100, 333, 1000, 3330, and 5000 µg/plate in the absence and presence of S9-mix.
Table 1. Strain TA100 - Without S9 -mix
Plate Dose (micrograms/plate) |
1 |
2 |
3 |
Mean |
SD |
Positive control |
1039 |
990 |
983 |
1004± |
31 |
Solvent control |
99 |
94 |
112 |
102± |
9 |
3 |
95 |
87 |
85 |
89 ± |
5 |
10 |
84 |
101 |
86 |
90± |
9 |
33 |
123 |
139 |
107 |
123 ± |
16 |
100 |
106 |
100 |
94 |
100 ± |
6 |
333 |
111 |
110 |
108 |
110 ± |
2 |
1000 |
87 |
95 |
109 |
97 ± |
11 |
3330 |
84 |
106 |
84 |
91 ± |
13 |
5000 |
175 |
111 |
101 |
129 ± |
40 |
Table 2. Strain TA100 With S9 -mix
Plate Dose (micrograms/plate) |
1 |
2 |
3 |
Mean |
SD |
Positive control |
1283 |
1347 |
1240 |
1290± |
54 |
Solvent control |
156 |
134 |
126 |
139± |
16 |
3 |
96 |
65 |
66 |
76± |
18 |
10 |
71 |
83 |
95 |
83± |
12 |
33 |
84 |
80 |
112 |
92± |
17 |
100 |
95 |
107 |
99 |
100± |
6 |
333 |
107 |
99 |
93 |
100± |
7 |
1000 |
102 |
86 |
94 |
94± |
8 |
3330 |
108 |
100 |
97 |
102± |
6 |
5000 | 95 | 139 | 105 | 113± | 23 |
No precipitation of Magnesium Hydroxide was observed on the plates at start or end of incubation period.
No reduction of the bacterial lawn and no biologically relevant decrease in the number of revertants were observed.
No increase in the number of revertants was observed upon treatment with Magnesium hydroxide under all conditions tested.
Mutation assay
Magnesium hydroxide was tested in the absense and presence of S9 -mix in two mutation assays. The first experiment was performed with the strains TA1535, TA1537 and TA98 and the second mutation was performed with strains TA1535, TA1537, TA98, TA100 andWP2uvrA. Results are in the tables below.
Table 3. Experiment 1: Mutagenic response of Magnesium hydorxide inSalmonella typhimuriumreverse mutation assay and in theEscherichia colirevers mutation assay.
Dose (µg/plate) |
Mean number of revertant colonies/3 replicate plates (± S.D.) with different strains ofSalmonells typhimuriumand oneEscherichia colistrain |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|
Without S9 -mix |
|||||
positive control |
857±14 |
343±11 |
982±89 |
1004±31 |
513± 1 |
solvent control |
6± 2 |
3±1 |
12±1 |
102±9 |
21±4 |
|
|
|
|
|
|
3 |
|
|
|
89±5 |
19±5 |
10 |
|
|
|
90±9 |
18±3 |
33 |
|
|
|
123±16 |
23±2 |
100 |
7±2 |
3±1 |
16±3 |
100±6 |
16±6 |
333 |
6±1 |
3±1 |
12±1 |
110±2 |
20±2 |
1000 |
5±1 |
4±1 |
14±5 |
97±11 |
18±4 |
3330 |
7±1 |
4±2 |
14±1 |
91±13 |
24±7 |
5000 |
8±1 |
3±0 |
16±3 |
129±40 |
25±3 |
With S9 -mix |
|||||
positive control |
155±11 |
300±31 |
940± 21 |
1290±54 |
282±20 |
solvent control |
6±1 |
3±0 |
17±3 |
139±16 |
17±5 |
|
|
|
|
|
|
3 |
|
|
|
76±18 |
18±2 |
10 |
|
|
|
83±12 |
18±5 |
33 |
|
|
|
92±17 |
17±3 |
100 |
8± 1 |
3±0 |
21±7 |
100±6 |
16±4 |
333 |
6±3 |
4±1 |
17± 1 |
100±7 |
23±2 |
1000 |
6±2 |
3±1 |
14±4 |
94±8 |
19±5 |
3330 |
7±1 |
3±0 |
17±3 |
102±6 |
23±3 |
5000 |
8±2 |
5±1 |
13±1 |
113±23 |
23±3 |
Table 4. Experiment 2: Mutagenic response of Magnesium hydroxide in theSalmonella typhimuriumreverse mutation assay and inEscherichia colireverse mutation assay.
Dose (µg/plate) |
Mean number of reverant colonies/3 replicate plates (±S.D.) with different strains ofSalmonella typhimuriumand oneEscherichia colistrain |
||||
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|
Without S9 -mix |
|||||
positive control |
735± 16 |
312±40 |
1109±31 |
958± 24 |
952±27 |
solvent control |
9±2 |
3±0 |
18±3 |
104±6 |
19±4 |
|
|
|
|
|
|
100 |
9±2 |
3±1 |
15±2 |
96±6 |
21±3 |
333 |
8±1 |
3±0 |
16±5 |
106±13 |
21±3 |
1000 |
6±1 |
6±1 |
19±4 |
98±4 |
21±3 |
3330 |
7±1 |
3±1 |
15±4 |
101±6 |
24±3 |
5000 |
7±3 |
3±0 |
14±3 |
103±10 |
22±4 |
With S9 -mix |
|||||
positive control |
125±18 |
368±8 |
669±33 |
745±48 |
176±18 |
solvent control |
4±1 |
3±0 |
19±2 |
61±2 |
20±4 |
|
|
|
|
|
|
100 |
7±4 |
3±1 |
18±1 |
66±5 |
20±4 |
333 |
7±1 |
3±0 |
22±4 |
68±3 |
21±4 |
1000 |
6±2 |
3±1 |
21±3 |
65±7 |
18± 2 |
3330 |
7±2 |
3±0 |
19±4 |
80±6 |
30±5 |
5000 |
7±3 |
4±2 |
19±3 |
105±6 |
28± 2 |
Precipitation of Magnesium hydroxide on the plates was not observed at the start or at the end of the incubation period.
In both mutation assays, there was no reduction of the bacterial background lawn and no biologically relevant decrease in the number of revertants at any of the concentrations tested in all tester strains in the absence and presence of S9 -mix.
In both assays, no increase in the number of revertants was observed upon treatment with Magnesium hydroxide under all conditions tested.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for read-across
Read-across from magnesium chloride to magnesium carbonate is justified on the following basis.
Due to the presence of acid, mainly in the form of hydrochloric acid, in the stomach, magnesium carbonate will be converted into magnesium chloride when orally ingested. Furthermore, magnesium chloride is significantly more soluble than the carbonate salt and therefore represents the worst case in terms of its bioavailability for systemic absorption.
In addition, both salts have been shown to have no acute toxicity and do not exhibit evidence of systemic toxicity when tested at a concentration of 2000 mg/kg bw in acute oral studies.
Magnesium carbonate and magnesium chloride also occur in the natural environment and humans are widely exposed to naturally occurring magnesium carbonate and chloride, e.g. via drinking water and food on a day to day basis. Ingested magnesium, carbonate and chloride ions are actively regulated by the body. Any systemic toxicity is likely to be caused by absorption of the magnesium ion rather than either the carbonate or chloride counterions and hence studies on magnesium salts can be read across from one to the other.
Genotoxicity data
The key study for in vitro genotoxicity (Magnesium carbonate) were performed on the analogue substances magnesium chloride. The results of an in vitro gene mutation study in bacteria (Ishidate et al, 1984) and the supporting study for in vitro chromosome aberration study in mammalian cells (Ishidate et al, 1984) were all negative. As detailed in the read across justification, these studies are directly applicable to magnesium carbonate. Hence magnesium carbonate is not considered to be genotoxic based on the results from in vitro studies.
Justification for classification or non-classification
Three studies were carried out on Magnesium hydroxide, Magnesium oxide and Magnesium carbonate according to current guidelines; a bacteria reverse mutation study. The results of these studies were negative. Therefore Upsalite is not classified as mutagenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.